Akero Therapeutics Inc (NASDAQ:AKRO)
| 17.91 Delayed Data As of Dec 04 |  +0.25 / +1.42%Today’s Change | 11.25 Today|||52-Week Range 58.38 | -67.32% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2017 | 2018 | -- | -- | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | -- | -- | -- |
| Operating Expenses | Gross Income | 0.00 | 0.00 | -- | -- | -- |
| General Expenses | 4.6M | 13.8M | -- | -- | ||
| Research And Development | 3.5M | 11.9M | -- | -- | ||
| Total Operating Expenses | 4.6M | 13.8M | -- | -- | ||
| Non-Operating Expenses | Operating Income | -4.6M | -13.8M | -- | -- | |
| Extraordinary Charge | 0.00 | -67.9M | -- | -- | ||
| Other Expenses | 0.00 | -21.0K | -- | -- | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -4.6M | -81.7M | -- | -- | |
| Preferred Dividend | -213.0K | -520.0K | -- | -- | ||
| Net Income | -4.6M | -81.7M | -- | -- | ||
| Shares To Calculate EPS | Shares To Calculate EPS | -- | 27.0M | -- | -- | |
| Shares To Calculate EPS Diluted | -- | 27.0M | -- | -- | ||
| Earnings Per Share | EPS | -- | -$3.04 | -- | -- | |
| EPS Diluted | -- | -$3.04 | -- | -- | ||
